Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin for Cystic Fibrosis
NCT00205634Phase 2Completed
- Sponsor
- Wake Forest University
- Start
- Dec 2000
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of clarithromycin in cystic fibrosis (CF), sponsored by Wake Forest University. Primary endpoints: Pulmonary Function Testing - FEV1 and Quality of Life. Started Dec 2000; status: completed.
02
Drugs
clarithromycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00205634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00205634.